Analysis of risk factors for hospital-acquired acute kidney injury during extracorporeal membrane oxygenation support
摘要
目的 探讨体外膜肺氧合(ECMO)辅助治疗期间医院获得性急性肾损伤(HA-AKI)的危险因素,并筛选可预测指标.方法 回顾性分析2021年1月至2026年2月在徐州医科大学附属医院因各种原因接受ECMO治疗的67例患者的临床资料,根据ECMO期间是否发生HA-AKI分为HA-AKI组(28例)和非HA-AKI组(39例),采用单因素分析和二元logistic回归分析ECMO期间发生AKI的危险因素.结果 67例患者中,HA-AKI发生率为41.8%;多因素 logistic 分析显示,降钙素原(OR=1.271,95%CI 1.025~1.575,P=0.029)及血红蛋白(Hb)(OR=1.037,95%CI 1.010~1.064,P=0.006)是ECMO期间发生HA-AKI的独立危险因素;联合预测因子的曲线下面积(AUC)为0.731(95%CI 0.604~0.857),最佳截断值为0.31时,灵敏度82.1%,特异度56.4%;HA-AKI组在院病死率(P=0.006)、连续性肾脏替代治疗(CRRT)使用率(P=0.010)及撤机时血管活性药物评分(VIS)(P=0.002)显著高于非HA-AKI组.结论 ECMO前24 h降钙素原及Hb是ECMO期间发生HA-AKI的独立危险因素,两者联合检测具有中等预测价值,以高灵敏度为特点,适用于临床高危患者的识别.发生HA-AKI患者在院病死率、CRRT使用率及撤机时VIS显著高于未发生HA-AKI患者.
Objective To investigate the risk factors for HA-AKI during ECMO therapy,and identify predictive indicators.Methods A retrospective analysis was conducted on the clinical data of 67 patients who received ECMO treatment at the Affiliated Hospital of Xuzhou Medical University between January 2021 and February 2026.Based on the occurrence of HA-AKI during ECMO,patients were divided into two groups:HA-AKI group(28 cases)and non-HA-AKI group(39 cases).Univariate analysis and binary logistic regression analysis were used to identify risk factors for AKI during ECMO.Results Among the 67 patients,the incidence of HA-AKI was 41.8%.Multivariate logistic analysis identified procalcitonin(OR=1.271,95%CI 1.025-1.575,P=0.029)and hemoglobin(OR=1.037,95%CI 1.010-1.064,P=0.006)as independent risk factors for hospital-acquired acute kidney injury during extracorporeal membrane oxygenation.The area under the receiver operating characteristic curve for the combined predictor was 0.731(95%CI:0.604-0.857).With an optimal cut-off value of 0.31,the combined predictor yielded a sensitivity of 82.1%and a specificity of 56.4%.The HA-AKI group demonstrated significantly higher in-hospital mortality(P=0.006),continuous renal replacement therapy(CRRT)utilization rate(P=0.010)and the vasoactive-inotropic score(VIS)at ECMO weaning(P=0.002)than the non-HA-AKI group.Conclusion Procalcitonin and hemoglobin levels measured within 24 hours prior to ECMO initiation are identified as independent risk factors for development of HA-AKI during ECMO support.The combined detection of these two demonstrates moderate predictive value,characterized by high sensitivity,which is suitable for the identification of high-risk patients in clinical practice.The HA-AKI patients exhibite significantly higher in-hospital mortality,CRRT utilization rate and VIS at ECMO weaning than the non-HA-AKI patients.